Tooth inflammation markers may predict treatment success
NCT ID NCT07261761
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 40 people with tooth inflammation (reversible or irreversible pulpitis) to see if certain immune markers in the blood (IL-8 and IL-10) could predict how well a tooth-saving treatment (vital pulp therapy) works. Participants received the therapy, and researchers checked for pain and healing using scans. The goal was to understand if these markers help diagnose the severity of inflammation and guide treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRREVERSIBLE PULPITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Dentistry, Mansoura Univeristy
Al Mansurah, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simpler procedure save children's aching baby teeth?
- Could a simpler dental procedure spare kids from a painful root canal?
- Could a simpler tooth procedure spare kids from root canals?
- Bee glue vs. toothache: could propolis replace standard pulpotomy care?
- Could a tooth's own pulp be used to regenerate root canals?
- Pill or injection? trial tests which piroxicam method best eases root canal pain